Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 772-775

  Spangler, Sheila K ^a   Visalli, Melissa A ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; LEVOFLOXACIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SPARFLOXACIN;

ALCALIGENES FAECALIS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BURKHOLDERIA CEPACIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PENICILLINS; TIME FACTORS;

EID: 0030031422     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.772     Document Type: Article

References (33)

1. Appelbaum, P. C., S. K. Spangler, and L. Sollenberger. 1986. Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin. norfloxacin, amifloxacin, pefloxacin and cefpirome. J. Antimicrob. Chemother. 18:675-679.
2. Appelbaum, P. C., S. K. Spangler, and T. Tamarree. 1988. Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin. Chemotherapy (Basel) 34:40-45.
3. Appelbaum, P. C., J. Tamim, J. Stavitz, R. C. Aber, and G. A. Pankuch. 1982 Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics. Eur. J Clin. Microbiol. 1:159-165.
4. Bergogne-Berezin, E., and M. L. Joly-Guillou. 1986. Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus. J. Antimicrob. Chemother 18(Suppl. E):35-39.
5. Bizet, C., E. Tekaia, and A. Philippon. 1993 In-vitro susceptibility of Alcaligenes faecalis compared with those of other Alcaligenes spp. to antimicrobial agents including seven β-lactams. J. Antimicrob. Chemother. 32:907-910
6. Cantón, E., J. Pemán, M. T. Jimenez, M. S. Ramón, and M. Gobernado. 1992. In vitro activity of sparfloxacin compared with those of five other quinolones Antimicrob Agents Chemother. 36:558-565.
7. Deeré, D., G. Artet, C. Danglot, J.-C. Lucet, G. Fournier, E. Bergogne-Bérézin, and A. Philippon. 1992 A β-lactamase-overproducing strain of Alcaligenes denitrificans subsp. xylosoxidans isolated from a case of meningitis J. Antimicrob. Chemother 30:769-779.
8. Dholakia, N., K. V. I. Rolston, D. H. Ho, B. LeBlanc, and G. P. Bodey. 1994. Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones Antimicrob. Agents Chemother. 38:848-852.
9. Fass, R. J., and J. Barnishan. 1980. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas ueruginosa to 32 antimicrobial agents. Rev. Infect. Dis. 2:841-853.
10. Fu, K. P., S. C. Lafredo, B. Foleno, D. M. Isaacson, J. F. Barrett, A. J. Tobia, and M. E. Rosenthale. 1992 In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob. Agents Chemother 36:860-866.
11. Gilligan, P. H. 1995. Pseudomonas and Burkholderia, p. 509-519. In P R. Murray, E. J. Baron, M. A Pfaller. F. C. Tenover, and R. II. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
12. Glupczynski, Y., W. Hensen, J. Freney, and E. Yourrasowsky. 1988. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents Antimicrob. Agents Chemother. 32:276-278.
13. Husson, M. O., D. Izard, L. Bouillet, and H. Leclerc. 1985. Comparative in-vitro activity of ciprofloxacin against non-fermenters. J. Antimicrob. Chemother 15:457-462.
14. Joly-Guillou, M. L., and E. Bergogne-Bérézin. 1992. In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp. J. Antimicrob Chemother. 29:466-468
15. Khardori, N., A. Reuben, B. Rosenbaum, K. Rolston, and G. P. Bodey. 1990. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob Agents Chemother. 34:1609-1610
16. Lecso-Bornet, M., J. Pierre, D. Sarkis-Karam, S. Lubera, and E. Bergogne-Berezin. 1992 Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob. Agents Chemother. 36:669-671.
17. Louie, A., A. L. Baltch, W. J. Ritz, and R. P. Smith. 1991. Comparative in vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp to sparfloxacin (CI-978, AT-4140, PD 131501) and reference antimicrobial agents. J. Antimicrob. Chemother. 27:793-799.
18. Mensah, K., A. Philippon, C. Richard, and P. Névot. 1990. Susceptibility of Alcaligenes denitrificans subspecies xylosoxidans to beta-lactam antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 9:405-409.
19. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed Approved standard NCCLS publication no. M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Neu, H. C., and N.-X. Chin. 1989 In vitro activity of S-ofloxacin. Antimicrob. Agents Chemother 33:1105-1107.
21. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother 38:2065-2072.
22. Raimondi, A., F. Moosdeen, and J. D. Williams. 1986. Antibiotic resistance pattern of Flavobacterium meningosepticum Eur. J. Clin. Microbiol Infect. Dis. 5:461-463.
23. Rolston, K. V. I., and G. P. Bodey. 1986. In vitro susceptibility of Acinetobacter species to various antimicrobial agents. Antimicrob. Agents Chemother. 30:769-770.
24. Rolston, K. V. I., D. H. Ho, B. LeBlanc, and G. P. Bodey. 1993. In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer. Antimicrob Agents Chemother. 37:2504-2505.
25. Rolston, K. V. I., H. Nguyen, M. Messer, B. LeBlanc, D. H. Ho, and G. P. Bodey. 1990. In vitro activity of sparfloxacin (CI-978, AT-4140) against clinical isolates from cancer patients. Antimicrob. Agents Chemother. 34: 2263-2266
26. Seifert, H., R. Baginski, A. Schulze, and G. Pulverer. 1993 Antimicrobial susceptibility of Acinetobacter species Antimicrob. Agents Chemother. 37: 750-753
27. Simor, A. E., L. Louie, and M. Louie. 1994 In vitro susceptibility of Acinetobacter baumannii to biapenem, piperacillin/tazobactam and thirteen other antimicrobial agents. Eur. J. Clin. Microbiol. Infect Dis. 13:521-523.
28. Smalley, D. L., V. R. Hansen, and V. S. Baselski. 1983. Susceptibility of Pseudomonas paucimobilis to 24 antimicrobial agents. Antimicrob. Agents Chemother 23:161-162.
29. Tanaka, M., M. Otsuki, T. Une, and T. Nishino. 1990. In-vivo and in-vivo activity of DR-3355, an optically active isomer of ofloxacin J. Antimicrob. Chemother. 26:659-666.
30. Vartivarian, S., E. Anaissie, G. Bodey, H. Sprigg, and K. Rolston. 1994 A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob. Agents Chemother. 38: 624-627.
31. Visser, M. R., M. Rozenberg-Arska, H. Beumer, I. M. Hoepelman, and J. Verhoef. 1991. Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. Antimicrob. Agents Chemother. 35:858-868.
32. Von Graevenitz, A. 1995. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria, p. 520-532. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C
33. von Graevenitz, A., and C. Bucher. 1982 The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans. Infection 10:293-298.